IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,450,951 | +15.5% | 252,446 | +4.5% | 0.97% | +16.9% |
| Q2 2023 | $9,911,699 | -8.6% | 241,572 | -20.4% | 0.83% | +9.7% |
| Q1 2023 | $10,842,408 | +19.1% | 303,369 | +25.9% | 0.76% | -5.1% |
| Q4 2022 | $9,101,626 | +2.0% | 240,975 | +19.4% | 0.80% | +3.0% |
| Q3 2022 | $8,927,074 | +179.4% | 201,833 | +133.8% | 0.77% | +241.0% |
| Q2 2022 | $3,195,233 | -45.7% | 86,311 | -45.7% | 0.23% | -49.8% |
| Q1 2022 | $5,882,174 | -49.8% | 158,806 | -58.7% | 0.45% | -39.6% |
| Q4 2021 | $11,709,129 | -22.5% | 384,789 | -14.6% | 0.75% | -28.7% |
| Q3 2021 | $15,109,804 | -14.3% | 450,501 | +1.9% | 1.05% | -10.7% |
| Q2 2021 | $17,631,380 | – | 442,000 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |